Sinotherapeutics Inc. (SHA:688247)
China
· Delayed Price · Currency is CNY 10.90
-0.03 (-0.27%)
At close: Jul 11, 2025, 2:57 PM CST
Sinotherapeutics Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Operating Revenue | 508.59 | 511.08 | 299.41 | 246.69 | 314.38 | 316 | Upgrade
|
Other Revenue | 0.54 | 0.54 | 0.46 | 0.87 | 1.09 | 3.16 | Upgrade
|
| 509.13 | 511.62 | 299.87 | 247.56 | 315.47 | 319.16 | Upgrade
| |
Revenue Growth (YoY) | 38.03% | 70.61% | 21.13% | -21.53% | -1.16% | 129.84% | Upgrade
|
Cost of Revenue | 250.78 | 246.11 | 133.5 | 68.44 | 70.44 | 61.41 | Upgrade
|
Gross Profit | 258.36 | 265.51 | 166.37 | 179.12 | 245.03 | 257.75 | Upgrade
|
Selling, General & Admin | 56.02 | 55.25 | 43.93 | 43.9 | 45.71 | 56.75 | Upgrade
|
Research & Development | 81.92 | 84.92 | 74.01 | 76.02 | 103.63 | 75.8 | Upgrade
|
Other Operating Expenses | 1.67 | 2.19 | 3.03 | -0.63 | 0.77 | 2.02 | Upgrade
|
Operating Expenses | 140.82 | 146.02 | 122.07 | 120.91 | 149.94 | 135.08 | Upgrade
|
Operating Income | 117.54 | 119.48 | 44.3 | 58.21 | 95.1 | 122.66 | Upgrade
|
Interest Expense | -0 | -0 | -0.04 | -0.21 | -0.23 | - | Upgrade
|
Interest & Investment Income | 15.85 | 16.38 | 17.45 | 25.02 | 5.66 | 26.16 | Upgrade
|
Currency Exchange Gain (Loss) | 2.07 | 2.07 | 1.26 | 5.52 | -4 | -12.08 | Upgrade
|
Other Non Operating Income (Expenses) | -0.17 | -0.07 | -0.06 | -0.05 | 0.43 | -0.59 | Upgrade
|
EBT Excluding Unusual Items | 135.28 | 137.86 | 62.91 | 88.48 | 96.95 | 136.15 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | - | 0.46 | - | Upgrade
|
Gain (Loss) on Sale of Assets | -0.59 | -0.59 | -0.11 | 0.12 | -0.02 | 0.04 | Upgrade
|
Asset Writedown | -1.4 | -0.92 | -1.62 | -0.85 | -0.1 | -0.09 | Upgrade
|
Other Unusual Items | 5.66 | 5.74 | 4.8 | 9.73 | 51.72 | 6.22 | Upgrade
|
Pretax Income | 138.96 | 142.08 | 65.99 | 97.48 | 149.01 | 142.32 | Upgrade
|
Income Tax Expense | 13.66 | 14.38 | 4.92 | 4.54 | 14.1 | 19.02 | Upgrade
|
Net Income | 125.29 | 127.7 | 61.07 | 92.93 | 134.92 | 123.3 | Upgrade
|
Net Income to Common | 125.29 | 127.7 | 61.07 | 92.93 | 134.92 | 123.3 | Upgrade
|
Net Income Growth | 64.31% | 109.09% | -34.28% | -31.12% | 9.42% | 2558.14% | Upgrade
|
Shares Outstanding (Basic) | 444 | 456 | 470 | 422 | 409 | 408 | Upgrade
|
Shares Outstanding (Diluted) | 444 | 456 | 470 | 422 | 409 | 408 | Upgrade
|
Shares Change (YoY) | -8.97% | -2.92% | 11.22% | 3.32% | 0.21% | - | Upgrade
|
EPS (Basic) | 0.28 | 0.28 | 0.13 | 0.22 | 0.33 | 0.30 | Upgrade
|
EPS (Diluted) | 0.28 | 0.28 | 0.13 | 0.22 | 0.33 | 0.30 | Upgrade
|
EPS Growth | 80.51% | 115.39% | -40.91% | -33.33% | 10.00% | 2900.00% | Upgrade
|
Free Cash Flow | 63.16 | 35.3 | -26 | -103.15 | 129.77 | 171.7 | Upgrade
|
Free Cash Flow Per Share | 0.14 | 0.08 | -0.06 | -0.24 | 0.32 | 0.42 | Upgrade
|
Dividend Per Share | 0.062 | 0.062 | 0.041 | 0.062 | - | - | Upgrade
|
Dividend Growth | 51.22% | 51.22% | -33.87% | - | - | - | Upgrade
|
Gross Margin | 50.74% | 51.90% | 55.48% | 72.35% | 77.67% | 80.76% | Upgrade
|
Operating Margin | 23.09% | 23.35% | 14.77% | 23.51% | 30.14% | 38.43% | Upgrade
|
Profit Margin | 24.61% | 24.96% | 20.37% | 37.54% | 42.77% | 38.63% | Upgrade
|
Free Cash Flow Margin | 12.41% | 6.90% | -8.67% | -41.67% | 41.13% | 53.80% | Upgrade
|
EBITDA | 134.65 | 137.79 | 67.38 | 83.75 | 121.21 | 135.27 | Upgrade
|
EBITDA Margin | 26.45% | 26.93% | 22.47% | 33.83% | 38.42% | 42.38% | Upgrade
|
D&A For EBITDA | 17.11 | 18.3 | 23.08 | 25.55 | 26.12 | 12.61 | Upgrade
|
EBIT | 117.54 | 119.48 | 44.3 | 58.21 | 95.1 | 122.66 | Upgrade
|
EBIT Margin | 23.09% | 23.35% | 14.77% | 23.51% | 30.14% | 38.43% | Upgrade
|
Effective Tax Rate | 9.83% | 10.12% | 7.45% | 4.66% | 9.46% | 13.36% | Upgrade
|
Revenue as Reported | 509.13 | 511.62 | 299.87 | 247.56 | 315.47 | 319.16 | Upgrade
|
Advertising Expenses | - | 0.77 | 0.42 | 0.69 | - | 0.08 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.